Prognostic factors in postoperative patients with cutaneous melanoma: a systematic review and meta-analysis

被引:2
作者
Xia, Qi [1 ]
Ma, Qinghua [2 ]
Zhu, Jiuqun [3 ]
Gu, Lu [4 ]
Zhou, Fengling [5 ]
机构
[1] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Day Chemotherapy Ctr, Dept PICC, Chengdu 610072, Sichuan, Peoples R China
[2] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Nursing, Chengdu 610072, Sichuan, Peoples R China
[3] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Pharm, Chengdu 610072, Sichuan, Peoples R China
[4] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Radiat, 32,West Second Sect,1st Ring Rd, Chengdu 610072, Sichuan, Peoples R China
[5] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Pediat, 32,West Second Sect,1st Ring Rd, Chengdu 610072, Sichuan, Peoples R China
关键词
Cutaneous melanoma; prognosis; prognostic factors; meta; -analysis; LYMPH-NODE BIOPSY; FEATURES;
D O I
10.62347/SQZT7285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cutaneous melanoma is a prevalent tumor associated with a poor prognosis. This systematic review and meta -analysis aimed to identify and evaluate prognostic factors for patients with cutaneous melanoma following surgery, thereby providing crucial insights for enhancing patient outcomes. We searched PubMed, Embase, Cochrane Library, CINAHL, and Web of Science for studies on postoperative prognostic factors of cutaneous melanoma up to March 2024. Literature screening, data extraction, and quality assessment were performed, followed by meta -analysis using RevMan 5.3 software. Trial Sequential Analysis (TSA) was conducted with Stata 17 software to verify the robustness of the findings. Eleven studies encompassing 27,352 patients were included. The metaanalysis identified several prognostic factors impacting disease -specific survival post -surgery: age over 50 years (HR=1.05, 95% CI: 1.02-1.08), female gender (HR=0.71, 95% CI: 0.57-0.87), Breslow thickness greater than 2 mm (HR=1.11, 95% CI: 1.06-1.17), presence of ulceration (HR=2.06, 95% CI: 1.63-2.60), and positive sentinel lymph node (HR=3.03, 95% CI: 2.50-3.66). TSA confirmed the adequacy of the sample size. Aggressive treatment strategies are recommended for patients exhibiting these characteristics to improve prognosis and extend 5 -year survival rates.
引用
收藏
页数:12
相关论文
共 33 条
[1]   Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment [J].
Ahmed, Bilal ;
Qadir, Muhammad Imran ;
Ghafoorb, Saba .
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2020, 30 (04) :291-297
[2]   Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma [J].
Amaral, Teresa M. S. ;
Hoffmann, Marie-Christine ;
Sinnberg, Tobias ;
Niessner, Heike ;
Suelberg, Heiko ;
Eigentler, Thomas K. ;
Garbe, Claus .
EUROPEAN JOURNAL OF CANCER, 2020, 125 :38-45
[3]   Temporal Trends in the Incidence and Mortality of Skin Malignant Melanoma in China from 1990 to 2019 [J].
Bai, Ruhai ;
Huang, Hui ;
Li, Minmin ;
Chu, Meng .
JOURNAL OF ONCOLOGY, 2021, 2021
[4]   Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic Phenotype [J].
Barricklow, Zoe ;
DiVincenzo, Mallory J. ;
Angell, Colin D. ;
Carson, William E. .
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 :1743-1757
[5]   Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal study [J].
Beesley, Vanessa L. ;
Hughes, Maria Celia B. ;
Smithers, B. Mark ;
Khosrotehrani, Kiarash ;
Malt, Maryrose K. ;
von Schuckmann, Lena A. ;
Green, Adele C. .
JOURNAL OF CANCER SURVIVORSHIP, 2020, 14 (05) :712-719
[6]   Acral lentiginous melanoma: a single-centre retrospective review of four decades in East-Central Europe [J].
Csanyi, I. ;
Houshmand, N. ;
Szucs, M. ;
Ocsai, H. ;
Kemeny, L. ;
Olah, J. ;
Baltas, E. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (09) :2004-2010
[7]   European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019 [J].
Garbe, Claus ;
Amaral, Teresa ;
Peris, Ketty ;
Hauschild, Axel ;
Arenberger, Petr ;
Bastholt, Lars ;
Bataille, Veronique ;
del Marmol, Veronique ;
Dreno, Brigitte ;
Fargnoli, Maria Concetta ;
Grob, Jean-Jacques ;
Hoeller, Christoph ;
Kaufmann, Roland ;
Lallas, Aimilios ;
Lebbe, Celeste ;
Malvehy, Josep ;
Middleton, Mark ;
Moreno-Ramirez, David ;
Pellacani, Giovanni ;
Saiag, Philippe ;
Stratigos, Alexander J. ;
Vieira, Ricardo ;
Zalaudek, Iris ;
Eggermont, Alexander M. M. .
EUROPEAN JOURNAL OF CANCER, 2020, 126 :159-177
[8]   Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual [J].
Gershenwald, Jeffrey E. ;
Scolyer, Richard A. ;
Hess, Kenneth R. ;
Sondak, Vernon K. ;
Long, Georgina V. ;
Ross, Merrick I. ;
Lazar, Alexander J. ;
Faries, Mark B. ;
Kirkwood, John M. ;
McArthur, Grant A. ;
Haydu, Lauren E. ;
Eggermont, Alexander M. M. ;
Flaherty, Keith T. ;
Balch, Charles M. ;
Thompson, John F. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) :472-492
[9]   A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma [J].
Hynes, Matthew C. ;
Nguyen, Paul ;
Groome, Patti A. ;
Asai, Yuka ;
Mavor, Meaghan E. ;
Baetz, Tara D. ;
Hanna, Timothy P. .
BMC CANCER, 2022, 22 (01)
[10]   Prognostic model for predicting overall and cancer-specific survival among patients with superficial spreading melanoma: A SEER based study [J].
Ji, Qiang ;
Tang, Jun ;
Li, Shulian ;
Chen, Junjie .
MEDICINE, 2022, 101 (52)